NCT00389415View on ClinicalTrials.gov

Long Term Safety of Vildagliptin (100mg qd) In Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

October 31, 2006

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Vildagliptin

Trial Locations (1)

Unknown

Novartis Pharmaceuticals, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY